The effect of freezing on the recovery and expansion of umbilical cord blood hematopoietic stem cells

Experimental and Clinical Transplantation

Volumn 7, Issue 1, 2009, Pages 50-55

  El Beshlawy, Amal ^a   Metwally, Hala G ^a   Abd El Khalek, Khalil ^a   Zayed, Rania A ^a   Hammoud, Rania F ^a   Mousa, Somaia M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Cryopreservation; Ex vivo expansion; Interleukin 3; Stem cell factor; Viability

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 3; STEM CELL FACTOR;

ARTICLE; CELL COUNT; CELL CULTURE; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; STEM CELL EXPANSION; UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELL; CELL CYCLE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CYTOLOGY; FEMALE; FETAL STEM CELL; FETUS BLOOD; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PREGNANCY; TIME;

ANTIGENS, CD34; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CULTURE MEDIA; FEMALE; FETAL BLOOD; FETAL STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; PREGNANCY; STEM CELL FACTOR; TIME FACTORS;

EID: 67649171679     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chua K, Chai C, Lee P, et al. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells. Exp Hematol. 2007;35(5):771-781.
2. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol. 2000;28(11):1197-1205.
3. Bertolini F, de Vincentiis A, Lanata L, et al. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects. Haematologica. 1997;82(2):220-238.
4. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351(22):2265-2275.
5. Fiquerres E, Haut PR, Olzewski M, et al. Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants. Bone Marrow Transplant. 2000;25(6):583-588.
6. Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol. 2003;48(1):35-43.
7. Paquette RL, Dergham ST, Karpf E, et al. Ex vivo expanded unselected peripheral blood progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood. 2000;96(7):2385-2390.
8. Lam AC, Li K, Zhang XB, et al. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media; serum supplements; and growth factors used; and engraftment in NOD/SCID mice. Transfusion. 2001;41(12):1567-1576.
9. Briddell RA, Kern BP, Zilm KL, et al. Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells. J Hematother. 1997;6(2):145-150.
10. Laroche V, McKenna DH, Moroff G, et al. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion. 2005;45(12):1909-1916.
11. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5(3):213-226.
12. Lakshmipathy U, Verfaillie C. Stem cell plasticity. Blood Rev. 2005;19(1):29-38.
13. Lowry PA, Zsebo KM, Deacon DH, et al. Effects of rSCF on multiple cytokine responsive HPP-CFC generated from SCA+Lin- murine hematopoietic progenitors. Exp Hematol. 1991;19(9):994-996.
14. Lemoli RM, Fortuna A, Fogli M, et al. Proliferative response of human myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Exp Hematol. 1995;23(14):1520-1526.
15. Rossmanith T, Schröder B, Bug G, et al. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells. Stem Cells. 2001;19(4):313-320.
16. Yang H, Zhao H, Acker JP, et al. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood. Cryobiology. 2005;51(2):165-175.
17. Moezzi L, Pourfathollah AA, Alimoghaddam K, et al. The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplant Proc. 2005;37(10):4500-4503.
18. Lazzari L, Lucchi S, Montemurro T, et al. Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood. Bone Marrow Transplant. 2001;28(7):693-698.
19. Sanchez-Garcia J, Torres A, Herrera C, et al. Cell cycle kinetic changes induced by interleukin-3 and interleukin-6 during ex vivo expansion of mobilized peripheral blood CD34 cells. Haematologica. 2006;91(1):121-124.
20. Ladd A, Pyatt R, Gothot A, et al. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0. Blood. 1997;90(2):658-668.